A cost-effective method for the biosynthesis of copper nanoparticles (Cu-NPLs) using Tilia extract under optimum conditions has been presented. The use of Tilia extracts for the synthesis of Cu-NPLs has been investigated for the first time. The Cu-NPLs are stable due to in situ bio-capping by the Tilia extract residues. Formation of metallic Cu was revealed by UV-vis and XRD analyses. UV-vis of Cu-NPLs showed an SPR characteristic peak at 563 nm (energy bandgap = 2.1 eV). Morphology and size of the as-prepared Cu-NPLs were determined using SEM and TEM studies. TEM observations show that the produced Cu-NPLs are hemispherical in shape with different diameters in the range 4.7–17.4 nm. The electrical conductivity of the Cu-NPLs was determined as 1.04 × 10−6 S cm-1 (at T = 120 K). The antimicrobial studies exhibited relatively high activity against pathogenic bacteria like Gram-positive & Gram-negative bacteria. Anticancer studies demonstrated the in vitro cytotoxicity value of Cu-NPLs against tested human colon cancer Caco-2 cells, human hepatic cancer HepG2 cells and human breast cancer Mcf-7 cells. To conclude, Cu-NPLs are promising in electronic devices and they possess a potential anticancer application for some human cancer therapy as well.
This report has two principal goals. First, to synthesis Se nanoparticles (Se-NPLs) via a green approach. Secondly, to explore the photocatalytic activity of Se-NPLs towards the decolorization of sunset yellow (SSY) azo-dye and to test its activity against some types of human cancers. Green synthesis of Se-NPLs from the leaf extracts of Drumstick was developed. Bio-synthesized Se-NPLs were characterized using FTIR, UV-vis, photoluminescence (PL), X-ray powder diffraction (XRD), scanning electron microscopy (SEM), energy dispersive analysis Xray (EDAX) and transmission electron microscopy (TEM) analyses. The UV-vis absorption maximum between 200 and 400 nm was due to the formation of SPR of Se-NPLs. FTIR revealed the Se-NPLs were synthesized, capped and stabilized with biomolecules present in the plant extracts. Se-NPLs exhibited an excitation peak at 399 nm and produced an emission peak at 599 nm. EDAX profile provided a signal of atomic Se (1.45 Kev).XRD confirmed the crystalline nature of Se-NPLs. SEM and TEM observations show that spherical Se particles appeared with diameters ranging from 23 to 35 nm. A possible mechanism of the reduction of (SeO 3 2 À ) to (Se 0 ) was discussed. The electrical conductivity was measured with temperature and the activation energy was calculated. The photocatalytic study conducted that Se-NPLs have the efficiency to degrade sunset yellow dye and the mechanism of degradation has been proposed. Se-NPLs have been shown to be effective against three types of human cancers (Caco-2 cells, HepG2 cells, and Mcf-7 cells). Se-NPLs are potent anticancer and inhibit the growth of the three cancer cells as indicated by the IC 50 values. To conclude, the green-synthesized Se-NPLs may be a candidate for further evaluation as a chemotherapeutic agent for some human cancer treatment.
A nicotinamide-based derivative was designed as an antiproliferative VEGFR-2 inhibitor with the key pharmacophoric features needed to interact with the VEGFR-2 catalytic pocket. The ability of the designed congener ((E)-N-(4-(1-(2-(4-benzamidobenzoyl)hydrazono)ethyl)phenyl)nicotinamide), compound 10, to bind with the VEGFR-2 enzyme was demonstrated by molecular docking studies. Furthermore, six various MD simulations studies established the excellent binding of compound 10 with VEGFR-2 over 100 ns, exhibiting optimum dynamics. MM-GBSA confirmed the proper binding with a total exact binding energy of −38.36 Kcal/Mol. MM-GBSA studies also revealed the crucial amino acids in the binding through the free binding energy decomposition and declared the interactions variation of compound 10 inside VEGFR-2 via the Protein–Ligand Interaction Profiler (PLIP). Being new, its molecular structure was optimized by DFT. The DFT studies also confirmed the binding mode of compound 10 with the VEGFR-2. ADMET (in silico) profiling indicated the examined compound’s acceptable range of drug-likeness. The designed compound was synthesized through the condensation of N-(4-(hydrazinecarbonyl)phenyl)benzamide with N-(4-acetylphenyl)nicotinamide, where the carbonyl group has been replaced by an imine group. The in-vitro studies were consonant with the obtained in silico results as compound 10 prohibited VEGFR-2 with an IC50 value of 51 nM. Compound 10 also showed antiproliferative effects against MCF-7 and HCT 116 cancer cell lines with IC50 values of 8.25 and 6.48 μM, revealing magnificent selectivity indexes of 12.89 and 16.41, respectively.
Graphene-based metal oxide nanocomposites are interesting and promising kinds of nanocomposites due to their large specific area, fast kinetics, and specific affinity towards heavy metal contaminants.
The release of Non-Steroidal Anti-Inflammatory drugs (NSAIDs) such as Ibuprofen (Ibu), Naproxen (Nab) and Diclofenac (Dic) to the aquatic system cause serious environmental problems. In this study, green-synthesized copper nanoparticles (Cu NPs) have been used as nano-adsorbent for the removal of Ibu, Nab, and Dic from wastewater samples. Formation of Cu NPs was confirmed by different analytical techniques. The adsorption parameters such as temperature, pH, adsorbate concentration, adsorbent dose and contact time were studied. The best removal results were obtained at these conditions: temperature 298 K, pH = 4.5, 10.0 mg Cu NPs, 60 min. At these conditions, the removal percentage of Ibu, Nap, and Dic were found to be 74.4, 86.9 and 91.4% respectively. The maximum monolayer adsorption capacities were calculated as 36.0, 33.9 and 33.9 mg/g for Dic, Nap, and Ibu respectively. The kinetic studies conducted that the sorption process obeyed the second order kinetic model, while the thermodynamic results revealed that the adsorption process was spontaneous, endothermic (+23.8, +40.8 and +38.3 kJ/mol for Ibu, Nap and Dic respectively). The results revealed that green-synthesized copper nano-adsorbent may be used for the removal of the anti-inflammatory drugs from real wastewater efficiently.
Corresponding to the reported features of anti-VEGFR-2-approved compounds, a new 1H-indole derivative (compound 7) was designed. The inhibitory potential of the designed compound was revealed via a molecular docking study that showed the appropriate binding. Then, MD simulation (six studies) over a period of 100 ns was performed to confirm the precise binding and optimum energy. Additionally, MM-GBSA reaffirmed the perfect binding, exhibiting a total precise energy of −40.38 Kcal/Mol. The MM-GBSA experiments named the essential amino acids in the protein–ligand interaction, employing the binding energy decomposition and revealing the diversity of interactions of compound 7 inside the VEGFR-2 enzyme. As compound 7 is new, DFT experiments were utilized for molecular structure optimization. Additionally, the DFT results validated the coherent interaction of compound 7 with the VEGFR-2 enzyme. A good value of drug-likeness of compound 7 was acknowledged via in silico ADMET studies. Interestingly, the experimental in vitro prohibitory potential of compound 7 was better than that of sorafenib, demonstrating an IC50 value of 25 nM. Notably, the strong inhibitory effects of compound 10 against two cancer cell lines (MCF-7 and HCT 116) were established with IC50 values of 12.93 and 11.52 μM, disclosing high selectivity indexes of 6.7 and 7.5, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.